Simon Tate - 26 Jun 2024 Form 4 Insider Report for Eliem Therapeutics, Inc. (CLYM)

Role
Director
Signature
/s/ William Cowles, Attorney-in-Fact
Issuer symbol
CLYM
Transactions as of
26 Jun 2024
Net transactions value
$0
Form type
4
Filing time
28 Jun 2024, 17:13:07 UTC
Previous filing
22 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELYM Stock Option (Right To Buy) Award $0 +10,000 $0.000000 10,000 26 Jun 2024 Common Stock 10,000 $7.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest on the earlier of June 26, 2025 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date.